Efficacy and safety of Tafolecimab in Chinese patients with type 2 diabetes and hypercholesterolemia: a post-hoc analysis of pooled data from three phase 3 trials

ABSTRACT:

SUBMITTER: Qi L 

PROVIDER: S-EPMC12224514 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature